Andrew C. Von Eschenbach insider trades

Open-market stock purchases and sales by Andrew C. Von Eschenbach, Director at Bausch & Lomb Corp, from SEC Form 4 filings since Jul 1, 2012.

Track record: 40% of 5 scored buys are up 5% or more since purchase, averaging +7%.

Recent trades

DateStockTradeValue
May 26, 2026BLCO Bausch & Lomb CorpBought (not open market)$250K
Feb 27, 2026BLCO Bausch & Lomb CorpBought$79.9K
Feb 27, 2026BLCO Bausch & Lomb CorpBought (not open market)—

Companies traded

  • BLCO Bausch & Lomb Corp: 2 buys, last May 26, 2026
  • TLSI TriSalus Life Sciences, Inc: other filings, last Aug 13, 2024
  • CELU Celularity Inc: other filings, last Jun 14, 2023
  • RDUS Radius Health, Inc: other filings, last Aug 15, 2022
  • BHC Bausch Health Companies Inc: 2 buys, last Aug 5, 2021
  • NONE Asterias Biotherapeutics, Inc: other filings, last Apr 1, 2014
  • BTX Biotime Inc: 1 buy, last Aug 12, 2013

Get free alerts when Andrew C. Von Eschenbach files a new trade →